Treatment of postprostatectomy urinary incontinence and erectile dysfunction: Is there insufficient access to care in Germany? von Baunacke, M., Schmidt, M-L., Groeben, C., Borkowetz, A., Thomas, C., Koch, R., Chun, F.K.H., Weissbach, L., Huber, J.

Volltext

A1079 - Urinary-exosomal transcript markers for discriminating indolent from aggressive disease of prostate cancer patients under active surveillance von Borkowetz, A., Gräfe, S., Thomas, C., Fuessel, S., Erdmann, K.

Volltext

Urinary-exosomal transcript markers for discriminating indolent from aggressive disease of prostate cancer patients under active surveillance von Borkowetz, A., Gräfe, S., Thomas, C., Fuessel, S., Erdmann, K.

Volltext

Prediction of significant prostate cancer in equivocal MRI lesions: a high-volume international multicenter study von Mahjoub, S., Sigle, A., Borkowetz, A., Von Hardenberg, J.

Volltext

A0062 - Prediction of significant prostate cancer in equivocal MRI lesions: a high-volume international multicenter study von Mahjoub, S., Sigle, A., Borkowetz, A., Von Hardenberg, J.

Volltext

Moderately Hypofractionated Proton Therapy with or without Implantable Spacer in Patients with Localized Prostate Cancer von Soborun, V.K., Funer, F., Borkowetz, A., Thiele, J., Löck, S., Thomas, C., Krause, M., Troost, E., Hölscher, T.

Volltext

PO-1482 Moderately hypofractionated proton therapy with implantable spacer in patients with prostate cancer von Soborun, V.K., Borkowetz, A., Thiele, J., Löck, S., Thomas, C., Troost, E.G.C., Krause, M., Hölscher, T.

Volltext

Combination of urinary-exosomal AMACR, ERG and PCA3 surpasses diagnostic power of serum PSA for patients with suspected prostate cancer von Erdmann, K., Borkowetz, A., Lohse-Fischer, A., Thomas, C., Fuessel, S.

Volltext

1693P CaboPoint: Final results from a phase II study of cabozantinib after checkpoint inhibitor (CPI) combinations in patients with advanced renal cell carcinoma (aRCC) von Albiges, L., Powles, T.B., Sharma, A., Venugopal, B., Bedke, J., Borkowetz, A., Gravis, G., Özdemir, B.C., Schnabel, M.J., Dutailly, P., Qvick, B., Perrot, V., Gruenwald, V.

Volltext

Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2018: Increasing case numbers facilitate more high-volume centers von Flegar, L., Baunacke, M., Groeben, C., Borkowetz, A., Kraywinkel, K., Eisenmenger, N., Thomas, C., Huber, J.

Volltext

MRI-guided active surveillance in patients with ISUP 1 prostate cancer – A multi-institutional validation of the discrimination of the PRECISE Score von Sushentsev, N., Wiesenfarth, M., Dixius, M., Kastner, C., Borkowetz, A., Platzek, I., Thomas, C., Kesch, C., Umutlu, L., Reis, H., Rau, T., Lenders, L., Spahn, M., Boschheidgen, M., Antoch, G., Albers, P., Barrett, T., Schimmöller, L., Hadaschik, B., Radtke, J.P.

Volltext

A0826 - MRI-guided active surveillance in patients with ISUP 1 prostate cancer – A multi-institutional validation of the discrimination of the PRECISE Score von Sushentsev, N., Wiesenfarth, M., Dixius, M., Kastner, C., Borkowetz, A., Platzek, I., Thomas, C., Kesch, C., Umutlu, L., Reis, H., Rau, T., Lenders, L., Spahn, M., Boschheidgen, M., Antoch, G., Albers, P., Barrett, T., Schimmöller, L., Hadaschik, B., Radtke, J.P.

Volltext

Urogenitale Tumoren nach Nierentransplantation – monozentrische Aufarbeitung der Inzidenzen und Überblick urologischer Vorsorgemaßnahmen von Putz, J., Kestel, V., Herout, R., Borkowetz, A., Leike, S., Thomas, C., Baunacke, M.

Volltext

AGREE II quality assessment of national and international clinical practice guidelines on prostate cancer von Beyer, K., Bhattacharya, Y., Murray, C., Smith, E.J., Boissier, R., Borkowetz, A., Dabestani, S., Willemse, P-P.M., Maresca, G., Rivas, J.G.M., Rajwa, P., Lardas, M., Grivas, N., Sakalis, V., Evans-Axelsson, S., Maclennan, S., Auweter, S., Thomas, M., Bjartell, A., Cornford, P., Kruger, H., N’dow, J., Roobol, M., Omar, M.I.

Volltext

A0859 - AGREE II quality assessment of national and international clinical practice guidelines on prostate cancer von Beyer, K., Bhattacharya, Y., Murray, C., Smith, E.J., Boissier, R., Borkowetz, A., Dabestani, S., Willemse, P-P.M., Maresca, G., Rivas, J.G.M., Rajwa, P., Lardas, M., Grivas, N., Sakalis, V., Evans-Axelsson, S., Maclennan, S., Auweter, S., Thomas, M., Bjartell, A., Cornford, P., Kruger, H., N’dow, J., Roobol, M., Omar, M.I.

Volltext

Urogenital tumors following kidney transplantation-monocentric analysis of incidences and overview of urological preventive measures von Putz, J, Kestel, V, Herout, R, Borkowetz, A, Leike, S, Thomas, C, Baunacke, M

Volltext

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis von Siltari, Aino, Pang, Karl, Shiranov, Kirill, Asiimwe, Alex, Evans-Axelsson, Susan, Franks, Billy, Kiran, Amit, Murtola, Teemu J., Schalken, Jack, Auvinen, Anssi, N’Dow, J., Smith, E.J., Ribal, M., Mottet, N., Moris, L., Lardas, M., Willemse, P-P., Gandaglia, G., Campi, R., Nicoletti, Rossella, Gacci, M., Briganti, A., Ratti, M.M., Alleva, E., Leardini, L., Sisca, E.S., Bangma, R., Roobol, M., Remmers, S., Tilki, D., Visakorpi, T., Tammela, T., van Hemelrijck, M., Bayer, K., Lejeune, S., Byrne, S., Fialho, L., Auffray, C., Hijazy, A., Power, S., van Bochove, K., Kalafati, M., Moinat, M., Voss, E., Horgan, D., Fullwood, L., Lancet, D., Bernstein, G., Omar, I., MacLennan, S., Maclennan, S., Tripathee, S., Wirth, M., Brenner, B., Borkowetz, A., Thomas, C., Horn, F., Reiche, K., Kreux, M., Josefsson, A., Hugosson, J., Huisman, H., Schalken, J., Hofmacher, T., Lindgren, P., Andersson, E., Zong, J., Butler-Ransohoff, J-E., Maass, M., Torremante, P., Voss, M.D., Devecseri, Z., Dau, C., Papineni, K., Snijder, R., Lambrecht, M., Wolfinger, R., Rogiers, S., Servan, A., Antoni, L., Pacoe, K., Robinson, P., Bakkard, D., Turunen, H., Kilkku, O., Voima, O., Nevalaita, L., Reich, C., Araujo, S., Longden-Chapman, E., Burke, D., Agapow, P., Derkits, S., Licour, M., McCrea, C., Payne, S., Yong, A., Thompson, L., Bussmann, M, Kotik, D.

Volltext

High diagnostic power of urinary-exosomal AMACR, ERG and PCA3 for patients with suspected prostate cancer von Erdmann, K., Borkowetz, A., Lohse-Fischer, A., Thomas, C., Fuessel, S.

Volltext

P135 Big data analysis of adverse events in metastatic hormone-sensitive prostate cancer systemic treatment using the PIONEER platform von Rajwa, P., Borkowetz, A., Abbott, T., Alberti, A., Bjartell, A., Brash, J., Chilelli, A., Davies, E., De Meulder, B., Golozar, A., Hijazy, A., Josefsson, A., Kolde, R., Kotik, D., Nicoletti, R., Oja, M., Prinsen, P., Ribal, M., Gómez Rivas, J., Smith, E., Snijder, R., Steinbeisser, C., Gandaglia, G., Cornford, P., Evans-Axelsson, S., N'dow, J., Peter-Paul, W.

Volltext

Urogenitale Tumoren nach Nierentransplantation – monozentrische Aufarbeitung der Inzidenzen und Überblick urologischer Vorsorgemaßnahmen von Putz, J., Kestel, V., Herout, R., Borkowetz, A., Leike, S., Thomas, C., Baunacke, M.

Volltext